NFKB1 and cancer: Before the CCA-1.1 synthesis, we also carried out a molecular docking study of CCA-1.1 compared to PGV-1 against several proteins as the cancer markers, including nuclear factor kappa B (NF-κB)-related signaling proteins and ROS metabolic enzymes.